Press "Enter" to skip to content

THE PITCH: TNeuroPharma received VC funding to commercialize a potential deterrent for Alzheimer's disease

One company in Albuquerque says it has the solution — with research to back up its claim. The startup, called TNeuroPharma, is commercializing two products meant to detect and deter Alzheimer’s.

Its platform is based on research conducted by TNeuroPharma’s…

Source: The Business Journal

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *